Patents by Inventor Anna Yulievna Spivak

Anna Yulievna Spivak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7803955
    Abstract: The contemplated invention relates to the field of synthesis of biologically active substances, namely to the synthesis of an acetate derivative of the main water-soluble ?-tocopherol metabolite known under the name of ?-CEHC, which is prepared by the acid-catalyzed reaction of condensation of trimethyl hydroquinone with linalool in boiling octane, using n-toluenesulfonic acid or (+)-camphor-10-sulfonic acid as the catalyst. The reaction is carried out for 3 hours at the trimethyl hydroquinone:linalool:catalyst mole ratio of 1:1:0.1. The forming product is acetylated with acetic anhydride in pyridine at room temperature for 0.5 hour, and then ozonized in acetone in the presence of Ba(OH)2, oxidized with Jones' reagent in acetone, and isolated on silica gel column chromatography. Said compound is an acetate derivative of the main ?-tocopherol metabolite—?-CEHC, for which high efficiency has been noted in treating disorders of the central nervous system.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: September 28, 2010
    Assignee: Institut Neftekhimii I Kataliza Ran
    Inventors: Anna Yulievna Spivak, Viktor Nikolaevich Odinokov, Oxana Valerievna Knyshenko
  • Publication number: 20090306413
    Abstract: The contemplated invention relates to the field of synthesis of biologically active substances, namely to the synthesis of an acetate derivative of the main water-soluble ?-tocopherol metabolite known under the name of ?-CEHC, which is prepared by the acid-catalyzed reaction of condensation of trimethyl hydroquinone with linalool in boiling octane, using n-toluenesulfonic acid or (+)-camphor-10-sulfonic acid as the catalyst. The reaction is carried out for 3 hours at the trimethyl hydroquinone:linalool:catalyst mole ratio of 1:1:0.1. The forming product is acetylated with acetic anhydride in pyridine at room temperature for 0.5 hour, and then ozonized in acetone in the presence of Ba(OH)2, oxidized with Jones' reagent in acetone, and isolated on silica gel column chromatography. Said compound is an acetate derivative of the main ?-tocopherol metabolite—?-CEHC, for which high efficiency has been noted in treating disorders of the central nervous system.
    Type: Application
    Filed: June 15, 2006
    Publication date: December 10, 2009
    Inventors: Anna Yulievna Spivak, Viktor Nikolaevich Odinokov, Oxana Valerievna Knyshenko